Search research articles
Contact Us
Filters
Showing results (61-70 of 302) with videos related to
Page
of 31
Sort By:
The Prostate
|
January 24, 2008
Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer
Alan A Aitchison, Abhi Veerakumarasivam, Maria Vias, et al.
Journal of Cell Science
|
July 1, 2004
CD133, a novel marker for human prostatic epithelial stem cells
Gavin D Richardson, Craig N Robson, Shona H Lang, et al.
ACS Chemical Biology
|
May 26, 2009
Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors
Rebecca M Myers, James W Shearman, Matthew O Kitching, et al.
Journal of Medical Screening
|
July 1, 2009
Stage shift in PSA-detected prostate cancers - effect modification by Gleason score
Nora Pashayan, Paul Pharoah, David E Neal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2009
Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Rhiannon C Macefield, J Athene Lane, Chris Metcalfe, et al.
Cancer Epidemiology
|
August 20, 2010
Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence
Nora Pashayan, Paul Pharoah, László Tabár, et al.
The Journal of Pathology
|
February 22, 2002
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer
Barry R Davies, Marie O'Donnell, Garrett C Durkan, et al.
BJU International
|
September 24, 2013
The first national clinical audit of prostate cancer care
Paul Cathcart, Julie Nossiter, Ajay Aggarwal, et al.
BJU International
|
April 2, 2011
Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK
Liz Down, Chris Metcalfe, Richard M Martin, et al.
European Urology
|
August 22, 2007
Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial
Kerry N L Avery, Jane M Blazeby, J Athene Lane, et al.
Page
of 31
Search research articles
Search
Showing results (61-70 of 302) with videos related to
Sort By:
Page
of 31
The Prostate
|
January 24, 2008
Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer
Alan A Aitchison, Abhi Veerakumarasivam, Maria Vias, et al.
Journal of Cell Science
|
July 1, 2004
CD133, a novel marker for human prostatic epithelial stem cells
Gavin D Richardson, Craig N Robson, Shona H Lang, et al.
ACS Chemical Biology
|
May 26, 2009
Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors
Rebecca M Myers, James W Shearman, Matthew O Kitching, et al.
Journal of Medical Screening
|
July 1, 2009
Stage shift in PSA-detected prostate cancers - effect modification by Gleason score
Nora Pashayan, Paul Pharoah, David E Neal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2009
Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Rhiannon C Macefield, J Athene Lane, Chris Metcalfe, et al.
Cancer Epidemiology
|
August 20, 2010
Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence
Nora Pashayan, Paul Pharoah, László Tabár, et al.
The Journal of Pathology
|
February 22, 2002
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer
Barry R Davies, Marie O'Donnell, Garrett C Durkan, et al.
BJU International
|
September 24, 2013
The first national clinical audit of prostate cancer care
Paul Cathcart, Julie Nossiter, Ajay Aggarwal, et al.
BJU International
|
April 2, 2011
Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK
Liz Down, Chris Metcalfe, Richard M Martin, et al.
European Urology
|
August 22, 2007
Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial
Kerry N L Avery, Jane M Blazeby, J Athene Lane, et al.
Page
of 31